Infectious Disease Diagnostic Market by Product, Technology, Testing Type, Sample, Application, End User - Global Forecast 2025-2030- Product Image

Sale

Infectious Disease Diagnostic Market by Product, Technology, Testing Type, Sample, Application, End User - Global Forecast 2025-2030

Report
194 Pages
October 2024
Region: Global
360iResearch™
ID: 4829907

UP TO €665EUR$697USD£554GBP OFF until Dec 31^st 2024

The Infectious Disease Diagnostic Market grew from USD 24.76 billion in 2023 to USD 26.44 billion in 2024. It is expected to continue growing at a CAGR of 7.29%, reaching USD 40.53 billion by 2030.

The Infectious Disease Diagnostics market encompasses a range of tests and technologies used to detect, identify, and monitor infectious agents in humans, including bacteria, viruses, fungi, and parasites. These diagnostics are crucial for controlling and mitigating the spread of infectious diseases, offering targeted treatment options and effective disease management. The applications are widespread, from clinical settings for patient diagnosis and treatment to monitoring public health and outbreak control. End-use sectors include hospitals, laboratories, academic institutions, and point-of-care testing environments. The key growth factors in the infectious disease diagnostics market include increased prevalence of diseases such as HIV, hepatitis, and COVID-19, advanced technology integration, and rising demand for rapid, accurate testing methods. Recent opportunities are marked by technological advancements like point-of-care testing and molecular diagnostic techniques that promise enhanced speed and precision. The growing focus on personalized medicine also presents a favorable market landscape, with AI and machine learning likely to streamline diagnostic processes and outcomes. However, the market faces challenges such as high costs associated with advanced diagnostic tests, regulatory hurdles, and varying healthcare infrastructures across regions that limit access. To succeed, companies must navigate these challenges by investing in cost-effective solutions and fostering collaborations with governments and healthcare organizations to ensure wide reach and compliance. Innovations in multiplex assays and automation in lab operations offer promising avenues for future research. Additionally, developments in digital health and telemedicine can expand the reach and functionality of infectious disease diagnostics. The market demonstrates a dynamic nature and firms that prioritize technology integration, affordability, and accessibility will likely gain a competitive edge, providing significant opportunities for those able to align closely with evolving healthcare needs and technological trends.

Understanding Market Dynamics in the Infectious Disease Diagnostic Market

The Infectious Disease Diagnostic Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing global prevalence and periodic outbreaks of infectious diseases
- Shift in focus towards decentralized point-of-care testing from centralized laboratories
- Supportive government initiatives and investments toward infectious disease control and prevention
Market Restraints
- Inadequate reimbursements and rising healthcare costs limiting the use of novel diagnostic techniques
Market Opportunities
- Advancements in infectious disease diagnostics kits and solutions
- Emergence of infectious disease diagnostics kits for homecare settings
Market Challenges
- Accuracy issues and limited availability of skilled professionals

Exploring Porter’s Five Forces for the Infectious Disease Diagnostic Market

Porter’s Five Forces framework further strengthens the insights of the Infectious Disease Diagnostic Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Infectious Disease Diagnostic Market

External macro-environmental factors deeply influence the performance of the Infectious Disease Diagnostic Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Infectious Disease Diagnostic Market

The Infectious Disease Diagnostic Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Infectious Disease Diagnostic Market

The Infectious Disease Diagnostic Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Infectious Disease Diagnostic Market

The Infectious Disease Diagnostic Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infectious Disease Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adaptive Biotechnologies Corporation, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Techne Corporation, bioMérieux SA, Cardinal Health Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., GE Healthcare, Grifols, S.A., Hologic Inc., Illumina, Inc., Johnson & Johnson Services, Inc., Konica Minolta, Inc., Labsystems Diagnostics Oy, Merck KGaA, Olympus Corporation, Perkin Elmer, Inc., Pfizer Inc., Qiagen N.V., Quest Diagnostics, Siemens Healthineers AG, Sysmex Corporation, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Infectious Disease Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Instruments
- Reagents
- Software & Services
Technology
- Biochemical Technology
- Conventional Technology
- Molecular Technology
Testing Type
- Laboratory Testing
- PoC Testing
Sample
- Blood, Plasma, & Serum
- Urine
Application
- Bacterial Infection
- Cardiovascular Infection
- CNS Infection
- Fungal Infection
- Sexually Transmitted Disease
- Viral Infection
End User
- Diagnostic Laboratories
- Hospital
- Research Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing global prevalence and periodic outbreaks of infectious diseases
5.1.1.2. Shift in focus towards decentralized point-of-care testing from centralized laboratories
5.1.1.3. Supportive government initiatives and investments toward infectious disease control and prevention
5.1.2. Restraints
5.1.2.1. Inadequate reimbursements and rising healthcare costs limiting the use of novel diagnostic techniques
5.1.3. Opportunities
5.1.3.1. Advancements in infectious disease diagnostics kits and solutions
5.1.3.2. Emergence of infectious disease diagnostics kits for homecare settings
5.1.4. Challenges
5.1.4.1. Accuracy issues and limited availability of skilled professionals
5.2. Market Segmentation Analysis
5.2.1. Product: Advancing applications of analytical instruments for infectious disease diagnostics
5.2.2. Testing Type: Emerging adoption of Point-of-Care (PoC) testing for convenience and emergency applications
5.2.3. Application: Increasing use of disease diagnosis kits to diagnose viral infections
5.2.4. End-User: Penetration of infectious disease diagnosis products in hospitals
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Infectious Disease Diagnostic Market, by Product

6.1. Introduction
6.2. Instruments
6.3. Reagents
6.4. Software & Services

7. Infectious Disease Diagnostic Market, by Technology

7.1. Introduction
7.2. Biochemical Technology
7.3. Conventional Technology
7.4. Molecular Technology

8. Infectious Disease Diagnostic Market, by Testing Type

8.1. Introduction
8.2. Laboratory Testing
8.3. PoC Testing

9. Infectious Disease Diagnostic Market, by Sample

9.1. Introduction
9.2. Blood, Plasma, & Serum
9.3. Urine

10. Infectious Disease Diagnostic Market, by Application

10.1. Introduction
10.2. Bacterial Infection
10.3. Cardiovascular Infection
10.4. CNS Infection
10.5. Fungal Infection
10.6. Sexually Transmitted Disease
10.7. Viral Infection

11. Infectious Disease Diagnostic Market, by End User

11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Hospital
11.4. Research Institutes

12. Americas Infectious Disease Diagnostic Market

12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States

13. Asia-Pacific Infectious Disease Diagnostic Market

13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam

14. Europe, Middle East & Africa Infectious Disease Diagnostic Market

14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom

15. Competitive Landscape

15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.3.1. Medix Biochemica Acquires US-Based ViroStat to Expand Infectious Diseases Antibody Offering
15.3.2. Oxford Nanopore and bioMérieux to Enter into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics
15.3.3. Thermo Fisher Scientific Launches PCR Kits for Infectious Disease Detection in India
15.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. INFECTIOUS DISEASE DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 2. INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 15. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 17. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 21. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. INFECTIOUS DISEASE DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 27. INFECTIOUS DISEASE DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. INFECTIOUS DISEASE DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. INFECTIOUS DISEASE DIAGNOSTIC MARKET DYNAMICS
TABLE 7. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BIOCHEMICAL TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MOLECULAR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, PLASMA, & SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CARDIOVASCULAR INFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CNS INFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 54. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 55. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 61. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 86. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 87. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 92. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 93. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 104. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 105. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 140. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 141. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 156. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 158. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 159. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 160. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 165. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 166. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. FINLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. FINLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. FINLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 171. FINLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 172. FINLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. FINLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. FRANCE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. FRANCE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. FRANCE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 177. FRANCE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 178. FRANCE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. FRANCE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. GERMANY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. GERMANY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. GERMANY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 183. GERMANY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 184. GERMANY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. GERMANY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. ITALY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. ITALY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. ITALY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 195. ITALY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 196. ITALY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. ITALY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. NORWAY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. NORWAY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. NORWAY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 213. NORWAY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 214. NORWAY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. NORWAY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. POLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. POLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 218. POLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 219. POLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 220. POLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. POLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. QATAR INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. QATAR INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. QATAR INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 225. QATAR INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 226. QATAR INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. QATAR INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. SPAIN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 247. SPAIN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 248. SPAIN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 249. SPAIN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 250. SPAIN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. SPAIN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. TURKEY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 265. TURKEY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 266. TURKEY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 267. TURKEY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 268. TURKEY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. TURKEY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. INFECTIOUS DISEASE DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023
TABLE 283. INFECTIOUS DISEASE DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Infectious Disease Diagnostic market, which are profiled in this report, include:

Abbott Laboratories
Adaptive Biotechnologies Corporation
Agilent Technologies, Inc.
Becton, Dickinson and Company
Bio-Techne Corporation
bioMérieux SA
Cardinal Health Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd.
GE Healthcare
Grifols, S.A.
Hologic Inc.
Illumina, Inc.
Johnson & Johnson Services, Inc.
Konica Minolta, Inc.
Labsystems Diagnostics Oy
Merck KGaA
Olympus Corporation
Perkin Elmer, Inc.
Pfizer Inc.
Qiagen N.V.
Quest Diagnostics
Siemens Healthineers AG
Sysmex Corporation
Thermo Fisher Scientific, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	194
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 26.44 Billion
Forecasted Market Value ( USD ) by 2030	$ 40.53 Billion
Compound Annual Growth Rate	7.2%
Regions Covered	Global
No. of Companies Mentioned	25

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3385EUR$3,545USD£2,818GBP €3761EUR$3,939USD£3,131GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€5989EUR$6,272USD£4,986GBP €6655EUR$6,969USD£5,539GBP

Understanding Market Dynamics in the Infectious Disease Diagnostic Market

Exploring Porter’s Five Forces for the Infectious Disease Diagnostic Market

Applying PESTLE Analysis to the Infectious Disease Diagnostic Market

Analyzing Market Share in the Infectious Disease Diagnostic Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Infectious Disease Diagnostic Market

Strategic Recommendations for Success in the Infectious Disease Diagnostic Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Additional Product Information:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT), Disease (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Flu) - Forecast to 2028

North America Infectious Disease Diagnostics Market Forecast to 2030 - Regional Analysis - By Product, Technology, Application Type, Testing Type, and End User

Asia Pacific Infectious Disease Diagnostics Market Forecast to 2030 - Regional Analysis - By Product, Technology, Application Type, Testing Type, and End User

Infectious Disease Diagnostics - Global Strategic Business Report

Global Infectious Diseases In-Vitro Diagnostics Market by Product (Instruments, Reagents, Software), Technology (Immunochemistry, Microbiology, Molecular Diagnostics), Indication, End-user - Forecast 2024-2030